Corcept Therapeutics Operating Cycle Over Time
| CORT Stock | USD 40.71 0.84 2.11% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Corcept Therapeutics Performance and Corcept Therapeutics Correlation. Is there potential for Pharmaceuticals market expansion? Will Corcept introduce new products? Factors like these will boost the valuation of Corcept Therapeutics. Projected growth potential of Corcept fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Corcept Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Earnings Share 0.78 | Revenue Per Share | Quarterly Revenue Growth 0.137 | Return On Assets |
Understanding Corcept Therapeutics requires distinguishing between market price and book value, where the latter reflects Corcept's accounting equity. The concept of intrinsic value—what Corcept Therapeutics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Corcept Therapeutics' price substantially above or below its fundamental value.
It's important to distinguish between Corcept Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Corcept Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Corcept Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Cycle Analysis
Compare Corcept Therapeutics and related stocks such as Halozyme Therapeutics, Abivax SA American, and Rhythm Pharmaceuticals Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HALO | 3.1 K | 818 | 1 K | 421 | 147 | 206 | 200 | 85.8099 | 887 | 346 | 645 | 317 | 390 | 345 | 436 | 501 | 733 |
| ABVX | 10.9 K | 10.9 K | 10.9 K | 10.9 K | 13 K | 6.3 K | 11.6 K | 3.7 K | 3.3 K | (424 K) | 209.6 K | 91.6 K | 63.3 K | 1.5 K | 530 | 477 | 501 |
| RYTM | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 595 | 408 | 564 | 507 | 351 |
| CYTK | 0.5125 | 1.2775 | 0.1931 | 0.0595 | 363 | 0.1528 | 0.0823 | 30.3621 | 50.8334 | 70.139 | 28.8977 | 269 | 0.5672 | 62.1906 | 329 | 378 | 297 |
| JAZZ | 339 | 148 | 170 | 155 | 151 | 127 | 175 | 194 | 210 | 284 | 295 | 955 | 547 | 567 | 458 | 412 | 224 |
| CAI | 163 | 132 | 131 | 111 | 122 | 112 | 104 | 105 | 145 | 140 | 179 | 153 | 153 | 148 | 140 | 161 | 189 |
| AXSM | 578 | 578 | 578 | 578 | 578 | 578 | 578 | 578 | 578 | 578 | 578 | 578 | 578 | 340 | 307 | 353 | 449 |
| NUVL | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| RNA | 64.5351 | 64.5351 | 64.5351 | 64.5351 | 64.5351 | 64.5351 | 64.5351 | 64.5351 | 64.5351 | 64.5351 | 64.5351 | 35.2241 | 153 | 329 | 945 | 851 | 893 |
Corcept Therapeutics and related stocks such as Halozyme Therapeutics, Abivax SA American, and Rhythm Pharmaceuticals Operating Cycle description
My Equities
My Current Equities and Potential Positions
| Corcept Therapeutics Incorporated | CORT |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 101 Redwood Shores |
| Exchange | NASDAQ Exchange |
USD 40.71
Additional Tools for Corcept Stock Analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.